Dali Cai Selected Research

Dali Cai Research Topics

3	Leukemia 01/2021 - 03/2006
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2018 - 01/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 03/2006
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Infections 01/2022
1	Cytomegalovirus Infections (Inclusion Disease) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Philadelphia Chromosome 03/2006

2	Imatinib Mesylate (Gleevec)FDA Link 03/2007 - 01/2003
1	Leflunomide (Arava)FDA LinkGeneric 01/2022
1	Tyrosine Kinase InhibitorsIBA 11/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2018
1	Arsenic Trioxide (Trisenox)FDA Link 02/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2014
1	Histones (Histone)IBA 03/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2006
1	fms-Like Tyrosine Kinase 3IBA 03/2006
1	Valproic Acid (Depakote)FDA LinkGeneric 03/2006
1	Interferon-alpha (Interferon Alfa)IBA 01/2003
1	Myeloblastin (Proteinase 3)IBA 01/2003
1	Phosphotransferases (Kinase)IBA 01/2003

2	Therapeutics 01/2021 - 03/2006
1	Stem Cell Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Aftercare (After-Treatment) 03/2006